We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.24%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$73.5B
AUM Growth
-$7.73B
(-9.5%)
Cap. Flow
-$10.4B
Cap. Flow
% of AUM
-14.12%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
2,549
New
227
Increased
861
Reduced
712
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$301M |
| 2 |
Estee Lauder
EL
|
+$252M |
| 3 |
Boeing
BA
|
+$251M |
| 4 |
Kenvue
KVUE
|
+$174M |
| 5 |
Fidelity National Information Services
FIS
|
+$166M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$547M |
| 2 |
Union Pacific
UNP
|
+$459M |
| 3 |
Pinnacle West Capital
PNW
|
+$203M |
| 4 |
Wells Fargo
WFC
|
+$199M |
| 5 |
Bank of America
BAC
|
+$199M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.75% |
| 2 | Healthcare | 13.74% |
| 3 | Financials | 13.36% |
| 4 | Industrials | 11.58% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
OmniAb
OABI
$325M
| $22K | ﹤0.01% |
4,341
| – | – |
|
1877
Belpointe PREP
OZ
$185M
| $22K | ﹤0.01% |
+260
| New | +$22.5K |
|
|
BLUE
1878
DELISTED
bluebird bio
BLUE
| $21K | ﹤0.01% |
363
+17
| +5% | +$1.19K |
|
1879
Caribou Biosciences
CRBU
$163M
| $21K | ﹤0.01% |
4,652
+188
| +4% | +$1.17K |
|
|
MGIC
1880
DELISTED
Magic Software Enterprises
MGIC
| $21K | ﹤0.01% |
1,908
-3,572
| -65% | -$43.6K |
|
1881
Magnite
MGNI
$3.48B
| $21K | ﹤0.01% |
2,790
| – | – |
|
1882
Stoke Therapeutics
STOK
$2.06B
| $21K | ﹤0.01% |
5,557
+2,723
| +96% | +$17.9K |
|
1883
Tucows
TCX
$157M
| $21K | ﹤0.01% |
1,074
| – | – |
|
1884
Alto Ingredients
ALTO
$349M
| $20K | ﹤0.01% |
+4,710
| New | +$18.2K |
|
|
OSG
1885
Octave Specialty Group
OSG
$255M
| $20K | ﹤0.01% |
1,691
| – | – |
|
1886
JPMorgan BetaBuilders US Equity ETF
BBUS
$9.15B
| $20K | ﹤0.01% |
261
| – | – |
|
1887
CryoPort
CYRX
$741M
| $20K | ﹤0.01% |
1,503
-1,099
| -42% | -$16.2K |
|
1888
DigitalOcean
DOCN
$14.4B
| $20K | ﹤0.01% |
854
+462
| +118% | +$16.4K |
|
1889
Phinia Inc
PHIN
$2.74B
| $20K | ﹤0.01% |
+761
| New | +$21.1K |
|
|
SGMO
1890
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $20K | ﹤0.01% |
35,051
-45,027
| -56% | -$48.2K |
|
|
SLN
1891
Silence Therapeutics
SLN
$554M
| $20K | ﹤0.01% |
+2,170
| New | +$16K |
|
|
TSVT
1892
DELISTED
2seventy bio
TSVT
| $20K | ﹤0.01% |
5,302
+226
| +4% | +$1.48K |
|
1893
Textron
TXT
$15.1B
| $20K | ﹤0.01% |
+259
| New | +$19.3K |
|
1894
Univest Financial
UVSP
$1.21B
| $20K | ﹤0.01% |
1,201
| – | – |
|
|
ACLX
1895
DELISTED
Arcellx
ACLX
| $19K | ﹤0.01% |
553
+28
| +5% | +$965 |
|
1896
Cabot Corp
CBT
$4.52B
| $19K | ﹤0.01% |
+277
| New | +$19.3K |
|
1897
FS Bancorp
FSBW
$321M
| $19K | ﹤0.01% |
667
| – | – |
|
1898
H.B. Fuller
FUL
$3.18B
| $19K | ﹤0.01% |
284
| – | – |
|
1899
Nu Skin
NUS
$252M
| $19K | ﹤0.01% |
907
| – | – |
|
1900
uniQure
QURE
$3.15B
| $19K | ﹤0.01% |
2,930
+134
| +5% | +$1.21K |
|
Similar funds
QCM
Lazard Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, Lazard Asset Management held 2,549 positions worth $73.5B, down 9.5% from $81.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $10.4B in Q3 2023, closing 243 positions and reducing 712 holdings. Its most notable exit was Littelfuse, an estimated $24.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in ScottsMiracle-Gro worth $28.3M.
- Lazard Asset Management's largest Q3 2023 buy was ScottsMiracle-Gro: 548,310 shares worth $28.3M.
- Lazard Asset Management added most to PPL Corp in Q3 2023, an estimated $301M increase.
- Lazard Asset Management's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $547M.
- Lazard Asset Management fully exited Littelfuse in Q3 2023, selling an estimated $24.3M.
- Lazard Asset Management's ten largest holdings make up 24% of its $73.5B portfolio in Q3 2023.
- Lazard Asset Management opened 227 new positions and closed 243 in Q3 2023.
- Lazard Asset Management's portfolio value fell 9.5% quarter-over-quarter to $73.5B.
Based on Lazard Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.